Mast Biosurgery
Medical Devices, 6749 Top Gun St, San Diego, California, 92121, United States, 11-50 Employees
Phone Number: 85********
Who is MAST BIOSURGERY
Leading in the design, development, and production of bioresorbable polymer implants, and emerging new technologies for the use in variety of surgical applications within the biosurgery m...
Read More
- Headquarters: 6749 Top Gun St, San Diego, California, 92121, United States
- Date Founded: 2004
- Employees: 11-50
- Revenue: $10 Million to $25 Million
- Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 3841 | NAICS Code: 339112 | Show More
Does something look wrong? Fix it. | View contact records from MAST BIOSURGERY
MAST Biosurgery Org Chart and Mapping
Similar Companies to MAST Biosurgery
CareFusion
- 10001+
- $ 500 Million to 1 Billion
Dexcom
- 5001-10000
- $ 1 Billion and Over
Xenco Medical
- 11-50
- $ 1 Million to 5 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding MAST Biosurgery
Answer: MAST Biosurgery's headquarters are located at 6749 Top Gun St, San Diego, California, 92121, United States
Answer: MAST Biosurgery's phone number is 85********
Answer: MAST Biosurgery's official website is https://mastbio.com
Answer: MAST Biosurgery's revenue is $10 Million to $25 Million
Answer: MAST Biosurgery's SIC: 3841
Answer: MAST Biosurgery's NAICS: 339112
Answer: MAST Biosurgery has 11-50 employees
Answer: MAST Biosurgery is in Medical Devices
Answer: MAST Biosurgery top competitors include: CareFusion , Dexcom , Xenco Medical
Answer: MAST Biosurgery contact info: Phone number: 85******** Website: https://mastbio.com
Answer: Leading in the design, development, and production of bioresorbable polymer implants, and emerging new technologies for the use in variety of surgical applications within the biosurgery market. Before the advent of bioresorbable materials, the closure of soft tissue was limited to permanent materials such as nylon sutures. Advances in material sciences led to the development of bioresorbable polymer sutures that met the clinical needs of holding soft tissues together, while serving the patient's need of not remaining permanently in the body. The evolution of bioresorbable polymer technology facilitated the development of large bioresorbable polymer sheets that could span large tissue masses and subsequently hold them in place. The thin sheets facilitate the healing of larger tissue masses and virtually eliminating many adverse effects of permanent implants. Bioresorbable surgical thin sheet for soft tissue applications, made from polylactide (PLA): a copolymer of 70:30 Poly(L-lactide-co-D,L-lactide). Composed of lactic acid similar to that which occurs naturally in the human body, the copolymer maintains its strength during the healing process, and through hydrolysis slowly breaks down into lactic acid molecules. The molecules are ultimately metabolized into carbon dioxide and water and are released from the body through the lungs.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month